RACB

Research Alliance Corpor... (RACB)

Research Alliance Corporation II

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RACB

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/15	04 : 40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2023/02/15	04 : 19	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2023/02/14	21 : 42	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2023/02/14	20 : 27	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2023/02/09	07 : 17	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2023/01/11	04 : 30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2022/12/17	06 : 06	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:RACB	Research Alliance Corporation II
2022/12/07	06 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/29	07 : 16	Business Wire	Research Alliance Corp. II Will Redeem Public Shares	NASDAQ:RACB	Research Alliance Corporation II
2022/11/11	07 : 13	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/11	01 : 33	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/10	06 : 06	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/08	06 : 06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/02	21 : 40	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2022/11/02	01 : 57	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RACB	Research Alliance Corporation II
2022/10/26	05 : 06	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:RACB	Research Alliance Corporation II
2022/06/29	22 : 30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RACB	Research Alliance Corporation II
2022/06/16	02 : 17	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RACB	Research Alliance Corporation II
2022/05/13	06 : 08	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RACB	Research Alliance Corporation II
2022/03/30	05 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RACB	Research Alliance Corporation II
2022/03/19	05 : 08	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/22	20 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/15	07 : 43	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/15	05 : 28	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/15	00 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/14	20 : 29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/10	07 : 23	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RACB	Research Alliance Corporation II
2022/02/01	20 : 15	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RACB	Research Alliance Corporation II
2021/05/12	06 : 22	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:RACB	Research Alliance Corporation II
2021/04/28	22 : 07	Business Wire	POINT Biopharma Receives U.S. Nuclear Regulatory Commission Materials License for Indiana Facility	NASDAQ:RACB	Research Alliance Corporation II